Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD4-positive T lymphocytes, also called T helper cells, are a major subset of T cells characterized by expression of the CD4 surface molecule. They orchestrate and modulate adaptive immune responses by recognizing antigens presented by MHC class II molecules on antigen-presenting cells. Upon activation, these cells differentiate into multiple effector subsets (e.g., Th1, Th2, Th17, Treg) that direct diverse immune functions mainly via cytokine secretion. Modulation of their responses—through intrinsic or extrinsic signals—plays a central role in immunity against pathogens, tumor immunity, autoimmunity, and inflammatory diseases. While they are a primary target for immunomodulatory therapies, "CD4+ T lymphocyte response modulation" is not itself a molecular target, but encompasses various pathways and receptors involved in controlling CD4+ T cell activity.
Cytokine modulation: Drugs like IL-2 act through receptor-mediated stimulation, expanding or activating CD4+ T lymphocytes.\nImmune checkpoint inhibition: Antibodies block inhibitory pathways, enhancing CD4+ T cell activation.\nImmunosuppression: Agents like cyclosporine or steroids inhibit signaling pathways required for CD4+ T cell function.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T helper cell (CD4-positive T lymphocyte) (CD4+ T cell).